Cargando…
Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation
Peroxisome proliferator activated receptor λ coactivator 1α (PGC-1α) is a potent regulator of mitochondrial biogenesis and energy metabolism. In this study, we investigated the therapeutic potential of the secretome released from the adipose-derived stem cells (ASCs) transfected with PGC-1α (PGC-sec...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888642/ https://www.ncbi.nlm.nih.gov/pubmed/31717375 http://dx.doi.org/10.3390/ijms20225589 |
_version_ | 1783475278780039168 |
---|---|
author | Lee, Jaeim Kim, Ok-Hee Lee, Sang Chul Kim, Kee-Hwan Shin, Jin Sun Hong, Ha-Eun Choi, Ho Joong Kim, Say-June |
author_facet | Lee, Jaeim Kim, Ok-Hee Lee, Sang Chul Kim, Kee-Hwan Shin, Jin Sun Hong, Ha-Eun Choi, Ho Joong Kim, Say-June |
author_sort | Lee, Jaeim |
collection | PubMed |
description | Peroxisome proliferator activated receptor λ coactivator 1α (PGC-1α) is a potent regulator of mitochondrial biogenesis and energy metabolism. In this study, we investigated the therapeutic potential of the secretome released from the adipose-derived stem cells (ASCs) transfected with PGC-1α (PGC-secretome). We first generated PGC-1α-overexpressing ASCs by transfecting ASCs with the plasmids harboring the gene encoding PGC-1α. Secretory materials released from PGC-1α-overexpressing ASCs were collected and their therapeutic potential was determined using in vitro (thioacetamide (TAA)-treated AML12 cells) and in vivo (70% partial hepatectomized mice) models of liver injury. In the TAA-treated AML12 cells, the PGC-secretome significantly increased cell viability, promoted expression of proliferation-related markers, such as PCNA and p-STAT, and significantly reduced the levels of reactive oxygen species (ROS). In the mice, PGC-secretome injections significantly increased liver tissue expression of proliferation-related markers more than normal secretome injections did (p < 0.05). We demonstrated that the PGC-secretome does not only have higher antioxidant and anti-inflammatory properties, but also has the potential of significantly enhancing liver regeneration in both in vivo and in vitro models of liver injury. Thus, reinforcing the mitochondrial antioxidant potential by transfecting ASCs with PGC-1α could be one of the effective strategies to enhance the therapeutic potential of ASCs. |
format | Online Article Text |
id | pubmed-6888642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68886422019-12-09 Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation Lee, Jaeim Kim, Ok-Hee Lee, Sang Chul Kim, Kee-Hwan Shin, Jin Sun Hong, Ha-Eun Choi, Ho Joong Kim, Say-June Int J Mol Sci Article Peroxisome proliferator activated receptor λ coactivator 1α (PGC-1α) is a potent regulator of mitochondrial biogenesis and energy metabolism. In this study, we investigated the therapeutic potential of the secretome released from the adipose-derived stem cells (ASCs) transfected with PGC-1α (PGC-secretome). We first generated PGC-1α-overexpressing ASCs by transfecting ASCs with the plasmids harboring the gene encoding PGC-1α. Secretory materials released from PGC-1α-overexpressing ASCs were collected and their therapeutic potential was determined using in vitro (thioacetamide (TAA)-treated AML12 cells) and in vivo (70% partial hepatectomized mice) models of liver injury. In the TAA-treated AML12 cells, the PGC-secretome significantly increased cell viability, promoted expression of proliferation-related markers, such as PCNA and p-STAT, and significantly reduced the levels of reactive oxygen species (ROS). In the mice, PGC-secretome injections significantly increased liver tissue expression of proliferation-related markers more than normal secretome injections did (p < 0.05). We demonstrated that the PGC-secretome does not only have higher antioxidant and anti-inflammatory properties, but also has the potential of significantly enhancing liver regeneration in both in vivo and in vitro models of liver injury. Thus, reinforcing the mitochondrial antioxidant potential by transfecting ASCs with PGC-1α could be one of the effective strategies to enhance the therapeutic potential of ASCs. MDPI 2019-11-08 /pmc/articles/PMC6888642/ /pubmed/31717375 http://dx.doi.org/10.3390/ijms20225589 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Jaeim Kim, Ok-Hee Lee, Sang Chul Kim, Kee-Hwan Shin, Jin Sun Hong, Ha-Eun Choi, Ho Joong Kim, Say-June Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation |
title | Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation |
title_full | Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation |
title_fullStr | Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation |
title_full_unstemmed | Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation |
title_short | Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation |
title_sort | enhanced therapeutic potential of the secretome released from adipose-derived stem cells by pgc-1α-driven upregulation of mitochondrial proliferation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888642/ https://www.ncbi.nlm.nih.gov/pubmed/31717375 http://dx.doi.org/10.3390/ijms20225589 |
work_keys_str_mv | AT leejaeim enhancedtherapeuticpotentialofthesecretomereleasedfromadiposederivedstemcellsbypgc1adrivenupregulationofmitochondrialproliferation AT kimokhee enhancedtherapeuticpotentialofthesecretomereleasedfromadiposederivedstemcellsbypgc1adrivenupregulationofmitochondrialproliferation AT leesangchul enhancedtherapeuticpotentialofthesecretomereleasedfromadiposederivedstemcellsbypgc1adrivenupregulationofmitochondrialproliferation AT kimkeehwan enhancedtherapeuticpotentialofthesecretomereleasedfromadiposederivedstemcellsbypgc1adrivenupregulationofmitochondrialproliferation AT shinjinsun enhancedtherapeuticpotentialofthesecretomereleasedfromadiposederivedstemcellsbypgc1adrivenupregulationofmitochondrialproliferation AT honghaeun enhancedtherapeuticpotentialofthesecretomereleasedfromadiposederivedstemcellsbypgc1adrivenupregulationofmitochondrialproliferation AT choihojoong enhancedtherapeuticpotentialofthesecretomereleasedfromadiposederivedstemcellsbypgc1adrivenupregulationofmitochondrialproliferation AT kimsayjune enhancedtherapeuticpotentialofthesecretomereleasedfromadiposederivedstemcellsbypgc1adrivenupregulationofmitochondrialproliferation |